Award recordCONTRACT

BAYER HEALTHCARE PHARMACEUTICALS INC

PIID VA26016F4885· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6810 · CHEMICALS· FY2016· $254,310 net obligations· UEI V1EVGCK7XES8· NJ

Description

XOFIGO - RA-223 DICHLORIDE INJECTION

First action · last action
2015-10-01 · 2017-05-09
Transactions
3
First transaction's obligation
$239,938
Base + all options value (sum of deltas)
$254,310
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2202D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$279,938$0Base award · 2015-10-01 · this action $239,938 · running total $239,938Modification P00001 · 2016-08-23 · this action $40,000 · running total $279,938Modification P00002 · 2017-05-09 · this action -$25,628 · running total $254,310
  • Base2015-10-01+$239,938= $239,938
  • Mod P000012016-08-23+$40,000= $279,938
  • Mod P000022017-05-09-$25,628= $254,310
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2015-10-01+$239,938$239,938XOFIGO - RA-223 DICHLORIDE INJECTION
Mod P00001· FUNDING ONLY ACTION2016-08-23+$40,000$279,938XOFIGO - RA-223 DICHLORIDE INJECTION
Mod P00002· CLOSE OUT2017-05-09−$25,628$254,310XOFIGO - RA-223 DICHLORIDE INJECTION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI V1EVGCK7XES8)

AwardOffice · PSC / listingNet obligationsFY
36C25626N0492256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS$386,860FY2026
36C26226F0163262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$181,386FY2026
36C26026F0086260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$80,663FY2026
36C26126N0199261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$101,567FY2026
36C25626N0126256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS$214,783FY2026
36E79725A0028NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025

Other recipients under 6810 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26018P3900LIFE CHEMICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$80,976FY2018
VA26018P2530BSE PERFORMANCE, LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$24,960FY2018
VA26017F0129UNITED THERAPEUTICS CORP260-NETWORK CONTRACT OFFICE 20 (36C260)$91,147FY2017
VA26017J3080ARIAD PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$79,221FY2017
VA26016F1444LUNDBECK LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$6,829FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26016F4885_3600_V797P2202D_3600 · retrieved 2026-09-26.